Statement CSAT on Consensus statement of the European Atherosclerosis Society: Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis

Czech version

Authors: Michal Vrablík; Vladimír Bláha; Renata Cífková; Tomáš Freiberger; David Karásek; Pavel Kraml; Jan Piťha; Hana Rosolová; Vladimír Soška; Tomáš Štulc; Lukáš Zlatohlávek Za Výbor Čsat; Jana Mašková
Published in: AtheroRev 2023; 8(2): 66-76
Category: Guidelines

Sources

Číselné označení citované literatury odkazuje na citace v originální verzi Konsenzu:

Kronenberg F, Mora S, Stroes ESG et al. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: A European Atherosclerosis Society consensus statement. Eur Heart J 2022 : 43(39): 3925–3946. Dostupné z DOI: https://doi.org/10.1093/eurheartj/ehac361.

Labels

Angiology Diabetology Internal medicine Cardiology General practitioner for adults

The importance of nonstatin therapies for LDL-cholesterol lowering in the management of very high and high atherosclerotic cardiovascular risk

Bempedoic acid in the context of current hypolipidemic treatment options and the results of the CLEAR OUTCOMES trial

Genetic testing – polygenic score

Parallel intervention of arterial hypertension and dyslipidemia – from risk identification to successful prevention

Hyperlipidemic crisis as a risk factor for acute pancreatitis

An unconventional manifestation of severe hypercholesterolemia – sudden senzorineural hearing loss? Case report

Inclisiran receives reimbursement and enters clinical practice

Dvojnásob 25letý Michal Vrablík

Kulatý Vladimír Soška (nikoli však postavou)

Comments to recent literature of interest

Article was published in

Athero Review

2023 Issue 2